Last reviewed · How we verify
NCT04633915: COV-HD
Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.
trial in Dialysis in 51 participants. Completed in 18 July 2021.
18 July 2021
Quick facts
| Lead sponsor | Saint Petersburg State University, Russia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 51 |
| Start date | 26 November 2020 |
| Primary completion | 18 July 2021 |
| Estimated completion | 18 July 2021 |
| Sites | 1 location across Russia |
Conditions studied
Sponsor
Saint Petersburg State University, Russia
Who can join
18 and older, any sex, with Dialysis or Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is prospective cohort study aimed to compare antibody response against SARS-CoV-2 in dialysis patients and non-dialysis-dependent volunteers. The research hypothesis is that dynamic of IgG antibodies against SARS-CoV-2 will differ in two groups. To determine whether there is a statistically significant interaction between factors "group" and "time" on the titer of IgG antibodies against SARS-CoV-2, a two-way repeated measures ANOVA will be used.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04633915
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dialysis
Currently open trials in the same condition.
- NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
- NCT07013175 — Wise Choices in the Intensive Care Unit · NA · recruiting
- NCT07119593 — Exercise Intensity · NA · recruiting
- NCT06933472 — A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China · Phase 3 · recruiting
- NCT06905080 — Dialysis Catheter Caps Case Feasibility Study · NA · active not recruiting
Other Saint Petersburg State University, Russia trials
Trials by the same sponsor.
- NCT07116343 — Intrapleural Ropivacaine Infusion in Cardiac Surgery · Phase 4 · recruiting
- NCT07185334 — Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating · NA · active not recruiting
- NCT07106112 — Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy · NA · recruiting
- NCT06654401 — Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm · NA · recruiting
- NCT06626711 — Effect of Propofol and Sevoflurane Anesthesia on HSP70 Expression in Tumor Cells · EARLY_PHASE1 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04633915 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saint Petersburg State University, Russia
- Last refreshed: 3 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04633915.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing